Cost Of Revenue - InfuSystem Holdings Inc (F:1TZ) - Alpha Spread

InfuSystem Holdings Inc
F:1TZ

Watchlist Manager
InfuSystem Holdings Inc Logo
InfuSystem Holdings Inc
F:1TZ
Watchlist
Price: 5.65 EUR 0.89% Market Closed
Market Cap: 120.3m EUR
Have any thoughts about
InfuSystem Holdings Inc?
Write Note

InfuSystem Holdings Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InfuSystem Holdings Inc
Cost of Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
InfuSystem Holdings Inc
F:1TZ
Cost of Revenue
-$65.1m
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.4B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.3B
CAGR 3-Years
2%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$309.9B
CAGR 3-Years
-23%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$192B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$9B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is InfuSystem Holdings Inc's Cost of Revenue?
Cost of Revenue
-65.1m USD

Based on the financial report for Jun 30, 2024, InfuSystem Holdings Inc's Cost of Revenue amounts to -65.1m USD.

What is InfuSystem Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-15%

Over the last year, the Cost of Revenue growth was -21%. The average annual Cost of Revenue growth rates for InfuSystem Holdings Inc have been -18% over the past three years , -16% over the past five years , and -15% over the past ten years .

Back to Top